Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Zoetis Inc.

ZTSNYSE
Healthcare
Drug Manufacturers - Specialty & Generic
$127.28
$0.00(0.00%)
U.S. Market is Open • 12:50

Zoetis Inc. (ZTS) Stock Overview

Explore Zoetis Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap56.7B
P/E Ratio21.01
EPS (TTM)$6.02
ROE0.58%
Fundamental Analysis

AI Price Forecasts

1 Month$136.68
3 Months$96.94
1 Year Target$138.30

ZTS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Zoetis Inc. (ZTS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of A, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 57.25, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $138.30.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 21.01 and a market capitalization of 56.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.19%
5-Day Change
1.67%
1-Month Change
4.50%
3-Month Change
11.13%
6-Month Change
-17.84%
Year-to-Date (YTD) Change
2.28%
1-Year Change
-18.19%
3-Year Change
-24.17%
5-Year Change
-19.59%
All-Time (Max) Change
315.32%

Contact Information

973 822 7000
10 Sylvan Way, Parsippany, NJ, 07054

Company Facts

138,000 Employees
IPO DateFeb 1, 2013
CountryUS
Actively Trading

Frequently Asked Questions